Cytosorbents Corp Shares Near 52-Week Low - Market Mover
The shares closed 0.3% above its 52-week low of $3.86, with trading volume higher than its 30 day average
Jan 06, 2022 by Kwhen Finance Editors
Cytosorbents Corp (CTSO) shares closed today at 0.3% above its 52 week low of $3.86, giving the company a market cap of $168M. The stock is currently down 7.6% year-to-date, down 54.6% over the past 12 months, and down 32.7% over the past five years. This week, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 fell 1.9%.
Trading Activity
- Trading volume this week was 29.2% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.9.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Cytosorbents Corp | -4.0 | -7.6 | -54.6 | ||
| Dow Jones Industrial Average | -1.0 | 0.2 | 21.9 | -0.5 | 25.2 |
| S&P 500 Index | -1.9 | -1.4 | 27.8 | -0.6 | 31.3 |
| Health Care | -1.0 | -2.5 | 21.1 | -3.0 | 24.6 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 376.1%
- The company's stock price performance over the past 12 months lags the peer average by 1104.6%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Cytosorbents Corp | CTSO | 0 | -7.6 | -54.6 | ||
| Peer Avg | N/A | 11.1 | -1.6 | -4.5 | -7.0 | 9.4 |
| Boston Scientific Corp. | BSX | 55.7 | 1.3 | 18.8 | -6.0 | 25.8 |
| Hologic, Inc. | HOLX | 4.8 | -7.6 | -6.9 | ||
| Meridian Bioscience Inc. | VIVO | 6.1 | -1.0 | -0.5 | ||
| Nephros Inc | NEPH | 0 | -2.5 | -29.6 | ||
| Daxor Corporation | DXR | 0 | 0.1 | -8.9 | -36.1 | 30.9 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: